Journal of Virology, February 2001, p. 1095-1103, Vol. 75, No. 3
Hématologie Expérimentale,
Institut J. Bordet, 1000 Brussels,1 and
Centre d'Etude et de Recherches Vétérinaires et
Agrochimiques, 1180 Uccle,3 Belgium;
Veterinary Infectious Disease Organization, Saskatoon,
Saskatchewan, Canada2; and Centre de
Thérapie Génique, Institut Paoli-Calmettes, Marseille,
France4
Received 22 June 2000/Accepted 25 October 2000
Bovine leukemia virus (BLV) is closely associated with the
development of B-cell leukemia and lymphoma in cattle. BLV infection has also been studied extensively in an in vivo ovine model that provides a unique system for studying B-cell leukemogenesis. There is
no evidence that BLV can directly infect ovine B cells in vitro, and
there are no direct data regarding the oncogenic potential of the viral
Tax transactivator in B cells. Therefore, we developed ovine B-cell
culture systems to study the interaction between BLV and its natural
target, the B cell. In this study, we used murine CD154 (CD40 ligand)
and
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.3.1095-1103.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
CD154 Costimulated Ovine Primary B Cells, a Cell
Culture System That Supports Productive Infection by Bovine
Leukemia Virus
-chain-common cytokines to support the growth of B cells
isolated from ovine lymphoid tissues. Integrated provirus,
extrachromosomal forms, and viral transcripts were detected in
BLV-exposed populations of immature, rapidly dividing surface immunoglobulin M-positive B cells from sheep ileal Peyer's patches and
also in activated mature B cells isolated from blood. Conclusive evidence of direct B-cell infection by BLV was obtained through the use
of cloned B cells derived from sheep jejunal Peyer's patches. Finally,
inoculation of sheep with BLV-infected cultures proved that infectious
virus was shed from in vitro-infected B cells. Collectively, these data
confirm that a variety of ovine B-cell populations can support
productive infection by BLV. The development of ovine B-cell cultures
permissive for BLV infection provides a controlled system for
investigating B-cell leukemogenic processes and the pathogenesis of BLV infection.
*
Corresponding author. Mailing address: Institut J. Bordet, Hématologie Expérimentale, 121, Blvd. de Waterloo,
1000 Brussels, Belgium. Phone: (32) 2 541 37 39. Fax: (32) 2 541 34 53. E-mail: anne_vandenbroeke{at}compuserve.com.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»